NCT06080971 is a clinical trial in Neonatal Jaundice, sponsored by Assiut University.

Who is sponsoring NCT06080971?

NCT06080971 is sponsored by Assiut University.

What condition does NCT06080971 study?

NCT06080971 studies Neonatal Jaundice.

Is NCT06080971 still recruiting?

NCT06080971 is currently status unknown. Last updated 16 October 2023.

Last reviewed 2023-10-16 · How we verify

NCT06080971

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Persistent Neonatal Jaundice on Neonates and Childern

Status unknown Last updated 16 October 2023

What this trial tests

trial in Neonatal Jaundice in 100 participants. Status unknown.

Timeline

13 October 2023

Primary endpoint
31 December 2024

31 March 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	13 October 2023
Primary completion	31 December 2024
Estimated completion	31 March 2025

Conditions studied

Neonatal Jaundice — all drugs for Neonatal Jaundice →

Sponsor

Assiut University

Who can join

Adults 14 Days to 18, any sex, with Neonatal Jaundice. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Describe demographic and clinical data of neonates \& childern with (PNNJ) admitted to neonatology , hepatology \& hematology units of Assiut university children hospital(AUCH). Describe the distribution of etiologies of (PNNG) in neonates \& children at AUCH. Assess the outcome of (PNNJ) in neonates \& childern admitted to AUCH .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neonatal Jaundice

Currently open trials in the same condition.

NCT06963450 — NeoSCB App for Screening Jaundice in Newborns · recruiting
NCT06399146 — Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana · NA · recruiting
NCT05521607 — Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago) · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06080971 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 16 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06080971.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing